Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001171843-25-005877
Filing Date
2025-09-12
Accepted
2025-09-12 07:50:06
Documents
3
Period of Report
2025-09-12

Document Format Files

Seq Description Document Type Size
1 FORM 6-K f6k_091125.htm 6-K 6037
2 PRESS RELEASE exh_991.htm EX-99.1 10757
3 GRAPHIC image_001.jpg GRAPHIC 11171
  Complete submission text file 0001171843-25-005877.txt   33548
Mailing Address 55 UNIVERSITY AVENUE, SUITE 1003 TORONTO Ontario, Canada M5J 2H7
Business Address 55 UNIVERSITY AVENUE, SUITE 1003 TORONTO Ontario, Canada M5J 2H7 (416) 854-8884
Quantum Biopharma Ltd. (Filer) CIK: 0001771885 (see all company filings)

EIN.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39152 | Film No.: 251310060
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)